Article

For generations, the neuromuscular disorder care community has focused on
establishing the correct diagnosis and providing supportive care. As the
pathophysiology and genetics of these conditions became better understood, novel
treatments targeting the disease mechanism were developed. This has led to some
significant disease-modifying and supportive treatments for several neuromuscular
disorders. The current treatments for amyotrophic lateral sclerosis (ALS),
neuromuscular junction disorders, inflammatory myopathies, and myotonia are
reviewed. Additionally, investigational treatments for ALS, Duchenne muscular
dystrophy, and spinal muscular atrophy are discussed.
CI - Copyright (c) 2012 Elsevier Inc. All rights reserved.

Langue : ANGLAIS